Patents by Inventor Mathieu CINIER

Mathieu CINIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI SPECIFIC MOLECULES
    Publication number: 20240218036
    Abstract: The invention relates to proteins having multi-specific binding abilities by fusion of an OB-fold variant, in particular from the Sac7d family, to the light or heavy chain of an antibody.
    Type: Application
    Filed: February 7, 2024
    Publication date: July 4, 2024
    Applicant: AFFILOGIC
    Inventors: Olivier KITTEN, Mathieu CINIER, Simon HUET
  • ANTI-FACTOR C3 SAC7D VARIANTS AND THEIR MEDICAL USE FOR TREATING COMPLEMENT-MEDIATED DISORDERS
    Publication number: 20240166692
    Abstract: The invention relates to a polypeptide comprising a variant of a protein of the Sac7d family that specifically binds to the complement component 3 (C3) and/or the component C3b obtained after hydrolysis of C3, and inhibits the complement cascade.
    Type: Application
    Filed: March 18, 2022
    Publication date: May 23, 2024
    Inventors: Mathieu CINIER, Anne CHEVREL, Olivier KITTEN
  • COMPOUNDS AND METHODS FOR EXTENDING HALF LIFE OF BIOMOLECULES
    Publication number: 20240124531
    Abstract: The invention relates to variants of OB-fold proteins, in particular of the Sac7d family that bind to human and mouse serum albumin and that can be used to increase serum half-life of elements associated therewith.
    Type: Application
    Filed: February 14, 2022
    Publication date: April 18, 2024
    Inventors: Mathieu CINIER, Olivier KITTEN
  • Multi specific molecules
    Patent number: 11932674
    Abstract: The invention relates to proteins having multi-specific binding abilities by fusion of an OB-fold variant, in particular from the Sac7d family, to the light or heavy chain of an antibody.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: March 19, 2024
    Assignee: AFFILOGIC
    Inventors: Olivier Kitten, Mathieu Cinier, Simon Huet
  • ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
    Publication number: 20230203129
    Abstract: The present invention provides new polypeptide derivatives binding to Human Epidermal Growth Factor Receptor 2 (HER2) and their conjugates thereof, and to their use as a diagnostic agent, particularly for early detection, patient stratification and treatment monitoring of forms of cancer characterized by over-expression of HER2.
    Type: Application
    Filed: December 16, 2020
    Publication date: June 29, 2023
    Applicant: BRACCO IMAGING S.P.A.
    Inventors: Erika REITANO, Alessandro MAIOCCHI, Luisa POGGI, Federico CRIVELLIN, Simon HUET, Mathieu CINIER, Olivier KITTEN
  • VARIANTS OF SAC7D AND THEIR USE IN CANCER THERAPY
    Publication number: 20230120167
    Abstract: The invention relates to variants of OB-fold proteins, hi particular of the Sac7d family that bind PD-L1 or HSP110 and are able to be used alone or in combination for cancer treatment.
    Type: Application
    Filed: March 10, 2021
    Publication date: April 20, 2023
    Inventors: Mathieu CINIER, Anne CHEVREL, Olivier KITTEN
  • ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
    Publication number: 20230040008
    Abstract: The present invention provides new polypeptide derivatives binding to Human Epidermal Growth Factor Receptor 2 (HER2) and their conjugates thereof, and to their use as a diagnostic agent, particularly for early detection, patient stratification and treatment monitoring of forms of cancer characterized by over-expression of HER2.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 9, 2023
    Applicant: BRACCO IMAGING S.P.A.
    Inventors: Erika REITANO, Alessandro MAIOCCHI, Luisa POGGI, Federico CRIVELLIN, Simon HUET, Mathieu CINIER, Olivier KITTEN
  • BINDERS FOR INHIBITING FORMATION OF MULTIMERIC PROTEINS
    Publication number: 20210380647
    Abstract: The invention relates to variants of OB-fold proteins, in particular of the Sac7d family that are able to bind a subunit of a multimeric protein and inhibit the formation of the multimer.
    Type: Application
    Filed: October 6, 2019
    Publication date: December 9, 2021
    Inventors: Olivier KITTEN, Mathieu CINIER, Simon HUET, Anne CHEVREL
  • MULTI SPECIFIC MOLECULES
    Publication number: 20200277348
    Abstract: The invention relates to proteins having multi-specific binding abilities by fusion of an OB-fold variant, in particular from the Sac7d family, to the light or heavy chain of an antibody.
    Type: Application
    Filed: November 13, 2018
    Publication date: September 3, 2020
    Inventors: Olivier KITTEN, Mathieu CINIER, Simon HUET